唐纳德Denkhaus

导向器

唐纳德A. Denkhaus加入我们的董事会在2015年2月,目前主持公司董事会的审计委员会。自2005年以来,Denkhaus先生一直厨房,有限责任公司,是一家提供语言配音和电视行业字幕服务的主席兼首席财务官。从1970年到2002年,Denkhaus先生,谁被授权作为注册会计师,就职于安达信是一家全球性的专业服务机构,在那里他是22年,并担任过众多领导职务的审计合伙人,包括作为头of Andersen’s South Florida audit practice and, from 1998 through 2002, as Audit Practice Partner responsible for Andersen’s offices in Florida and Puerto Rico. From 2010 to 2013, Mr. Denkhaus was Chair of Nuovo Biologics, a privately held biotech company currently seeking FDA approval of an antiviral drug, and, from 2004 until its sale in 2009, Mr. Denkhaus served on the board of directors and as chair of the audit committee of Noven Pharmaceuticals, a publicly-traded specialty pharmaceutical company focused on women’s health and psychiatry. Mr. Denkhaus received a Masters in Business Administration degree with a major in finance from the University of Maryland and a Bachelors of Business Administration with a major in accounting from Kent State University.